IP Library › Granted Patent US 12,292,435
Granted Patent B2
US 12,292,435 · App. 17/978,096 · Granted May 6, 2025

Apparatus for diagnosing lung cancer based on exhaled breath and method for diagnosing same

Inventors: Dae-Sik Lee (Daejeon, KR); Sang Hoon Jheon (Seoul, KR); Hyung-Kun Lee (Daejeon, KR); Yoohwa Hwang (Seongnam-si, KR); Doyeob Kim (Daejeon, KR); Chang-Beom Kim (Daejeon, KR); Jin Oh Lee (Daejeon, KR)
Assignees: Electronics and Telecommunications Research Institute; Seoul National University Hospital
G01N33/497G01N1/2205G01N33/0047G01N33/0016G01N33/4975G01N2800/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,292,435
App. No.
17/978,096
Granted
May 6, 2025
Kind
B2
Abstract

Provided are an apparatus for diagnosing a disease and a method for diagnosing same. The apparatus includes a pump for pumping respiratory gas, a first pre-treatment portion connected to the pump and removing moisture and bad breath in the respiratory gas, and a volatile organic compound detector connected between the first pre-treatment portion and the pump and detecting volatile organic compounds in the respiratory gas.

Claims (56)

1. A disease diagnostic apparatus comprising:

a pump configured to pump respiratory gas;

a first pre-treatment portion connected to the pump and configured to remove moisture and bad breath in the respiratory gas;

a second pre-treatment portion disposed between the first pre-treatment portion and the pump and configured to regulate humidity of the respiratory gas;

a third pre-treatment portion disposed between the second pre-treatment portion and the pump and configured to regulate noise of non-polar volatile organic compounds in the respiratory gas;

a fourth pre-treatment portion which is connected between the third pre-treatment portion and the volatile organic compound detector and regulates noise of polar volatile organic compounds in the respiratory gas; and

a volatile organic compound detector connected between the third pre-treatment portion and the pump and configured to detect volatile organic compounds in the respiratory gas.

2. The disease diagnostic apparatus of claim 1 , wherein the fourth pre-treatment portion comprises:

a phenol bubbler configured to evaporate a phenol solution; and

a phenol gas sensor disposed between the phenol bubbler and the volatile organic compound detector and configured to detect a phenol gas in the volatile organic compounds.

3. The disease diagnostic apparatus of claim 2 , wherein the phenol bubbler comprises:

a phenol bath configured to store the phenol solution; and

a carrier gas supplier which is connected to the phenol bath and provides a carrier gas into the phenol solution to generate the phenol gas.

4. The disease diagnostic apparatus of claim 1 , wherein the first pre-treatment portion comprises:

a first chamber;

a moisture filter disposed inside the first chamber and configured to remove the moisture; and

a bad breath filter disposed between the moisture filter and the volatile organic compound detector and configured to remove the bad breath.

5. The disease diagnostic apparatus of claim 4 , wherein the first pre-treatment portion further comprises a first heater which is disposed in the first chamber and surrounds the moisture filter and the bad breath filter.

6. The disease diagnostic apparatus of claim 1 , wherein the second pre-treatment portion comprises:

a water bubbler configured to evaporate DI water; and

a hygrometer provided between the water bubbler and the volatile organic compound detector and configured to detect humidity of the respiratory gas.

7. The disease diagnostic apparatus of claim 6 , wherein the water bubbler comprises:

a water bath configured to store the DI water; and

a carrier gas supplier which is connected to the water bath and provides a carrier gas into the DI water to generate water vapor of the DI water.

8. The disease diagnostic apparatus of claim 6 , wherein the third pre-treatment portion comprises:

a benzene bubbler configured to evaporate a benzene solution; and

a non-polar volatile organic compound gas sensor disposed between the benzene bubbler and the volatile organic compound detector and configured to detect a benzene gas in the volatile organic compounds.

9. The disease diagnostic apparatus of claim 8 , wherein the benzene bubbler comprises:

a benzene bath configured to store the benzene solution; and

a carrier gas supplier which is connected to the benzene bath and provides a carrier gas into the benzene solution to generate the benzene gas.

10. A disease diagnostic apparatus comprising:

a first intake line;

a volatile organic compound detector configured to detect volatile organic compounds in respiratory gas;

a first pre-treatment portion connected between the volatile organic compound detector and the first intake line and configured to remove moisture and bad breath in the respiratory gas;

a second pre-treatment portion connected between the first pre-treatment portion and the volatile organic compound detector and configured to regulate humidity of the respiratory gas;

a third pre-treatment portion connected between the second pre-treatment portion and the volatile organic compound detector and configured to regulate noise of non-polar volatile organic compounds in the respiratory gas; and

a fourth pre-treatment portion connected between the third pre-treatment portion and the volatile organic compound detector and configured to regulate noise of polar volatile organic compounds in the respiratory gas.

11. The disease diagnostic apparatus of claim 10 , comprising:

a second intake line configured to connect the fourth pre-treatment portion to the volatile organic compound detector;

a third intake line configured to connect the first pre-treatment portion to the second pre-treatment portion;

a fourth intake line configured to connect the second pre-treatment portion to the third pre-treatment portion;

a fifth intake line configured to connect the third pre-treatment portion to the fourth pre-treatment portion; and

a first bypass line which is branched from the first intake line and connected to the second intake line, thereby bypassing the first pre-treatment portion.

12. The disease diagnostic apparatus of claim 11 , further comprising a second bypass line which is branched from the first bypass line and the second pre-treatment portion.

13. The disease diagnostic apparatus of claim 12 , further comprising a third bypass line which is branched from the second bypass line and the third pre-treatment portion.

14. The disease diagnostic apparatus of claim 13 , further comprising a fourth bypass line which bypasses the fourth pre-treatment portion.

15. A disease diagnostic method comprising:

pumping respiratory gas;

removing moisture in the respiratory gas by using a moisture filter;

removing bad breath in the respiratory gas by using a bad breath filter;

regulating humidity of the respiratory gas to reference humidity by evaporating DI water;

regulating concentration of benzene gas in the respiratory gas to first reference concentration by evaporating a benzene solution;

detecting volatile organic compounds in the respiratory gas by using a sensor array, thereby determining whether a lung cancer is in the human body; and

regulating concentration of phenol gas in the respiratory gas to second reference concentration by evaporating a phenol solution.

16. The disease diagnostic method of claim 15 , wherein the reference humidity is 40% to 60%.

17. The disease diagnostic method of claim 15 , wherein the first reference concentration is 0.1 ppm to 0.5 ppm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2022
From: LEE, DAE-SIK; JHEON, SANG HOON; LEE, HYUNG-KUN; HWANG, YOOHWA; KIM, DOYEOB; KIM, CHANG-BEOM; LEE, JIN OH
To: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE; SEOUL NATIONAL UNIVERSITY HOSPITAL
Reel/Frame 061602/0785 →
Priority Claims (1)
KR 10-2022-0033989 · Mar 18, 2022 · national
Continuity (1)
Related Publication 20230296583A1 · Sep 21, 2023
References Cited (33)
US 3317356A · Clendinning · 1967 [cited by examiner]
US 3776635A · Haskell · 1973 [cited by examiner]
US 5620564A · Akhtar · 1997 [cited by examiner]
US 5733515A · Doughty · 1998 [cited by examiner]
US 5824918A · Zuk · 1998 [cited by examiner]
US 6493638B1 · McLean · 2002 [cited by examiner]
US 9144396B2 · Choe · 2015 [cited by applicant]
US 20060257288A1 · Sun · 2006 [cited by examiner]
US 20080128285A1 · Moon et al. · 2008 [cited by applicant]
US 20110308522A1 · Kimm · 2011 [cited by examiner]
US 20130168548A1 · Wang · 2013 [cited by examiner]
US 20140165705A1 · Li · 2014 [cited by examiner]
US 20150250407A1 · Rigas · 2015 [cited by examiner]
US 20170105656A1 · Rigas · 2017 [cited by examiner]
US 20170191953A1 · Rigas · 2017 [cited by examiner]
US 20170299536A1 · Tsuboi et al. · 2017 [cited by applicant]
US 20180271406A1 · Furusaki et al. · 2018 [cited by applicant]
US 20190187135A1 · Kim et al. · 2019 [cited by applicant]
US 20200088668A1 · Swager · 2020 [cited by examiner]
US 20200179910A1 · Park · 2020 [cited by examiner]
US 20220039690A1 · Rigas · 2022 [cited by examiner]
CN 211927805U · 2020 [cited by examiner]
KR 20090019717A · 2009 [cited by applicant]
KR 20090061864A · 2009 [cited by examiner]
KR 1020100101876A · 2010 [cited by applicant]
KR 101521418B1 · 2015 [cited by applicant]
KR 20170082335A · 2017 [cited by applicant]
Staerz et al. “Understanding the Potential of WO3 Based Sensors for Breath Analysis”, Sensors 2016, 16, 1815 <https://www.mdpi.com/1424-8220/16/11/1815> (Year: 2016). [cited by examiner]
Bajtarevic et al. “Noninvasive detection of lung cancer by analysis of exhaled breath”, BMC Cancer 2009, 9, 348 <https://doi.org/10.1186/1471-2407-9-348> (Year: 2009). [cited by examiner]
Kim et al. “Gas sensor measurement system capable of sampling volatile organic compounds (VOCs) in wide concentration range”, Sensors and Actuators B: Chemical, vol. 122, Iss 1 (2007) 211-218 <https://doi.org/10.1016/j.… [cited by examiner]
Gang Peng et al., “Diagnosing lung cancer in exhaled breath using gold nanoparticles”, Nature Nanotechnology, Aug. 30, 2009, vol. 4, pp. 669-673. [cited by applicant]
Ji-Eun Chang et al., “Analysis of volatile organic compounds in exhaled breath for lung cancer diagnosis using a sensor system”, Sensors and Actuators B 255 (2018) 800-807, Feb. 2018. [cited by applicant]
Sung H. Lim et al., “An optoelectronic nose for the detection of toxic gases”, Nature Chemistry, Oct. 2009, vol. 1, pp. 562-567. [cited by applicant]